The effect and mechanisms of Myristica fragrans on blood clotting were evaluated by evaluating blood coagulation time and the fibrinolytic system. The compounds 2 and 5 were isolated from the herbal extract and their activities were assessed for the first time. None of the tested compounds had fibrinolytic activity, but could inhibit the fibrinolytic activity of urokinase. Compound 2 showed the highest inhibitory activity (IC50 = 1.747 mg·mL−1) followed by compounds 4 (IC50 = 1.818 mg·mL−1) and 1 (IC50 = 2.407 mg·mL−1), which were higher than that of the compound in Danshen drug tablets (IC50 = 6.577 mg·mL−1) used in China. Moreover, compounds 1 and 2 showed strong α-glucosidase inhibitory activity in a dose-dependent manner with IC50 values 21.76 ± 0.59 and 21.31 ± 0.00 μg·mL−1, respectively. These results demonstrated that the compounds are promising candidates as procoagulant and antidiabetic agents.
Get full access to this article
View all access options for this article.
References
1.
YuDJ: Myristica fragrans Houtt. In: Flora Reipublicae Popularis Sinicae, Vol. 30. Science Press, Beijing, 1979, p. 194.
2.
SongLR: Myristica fragrans Houtt. In: Chinese Materia Medica, Vol. 7. Shanghai Scientific Technology Press, Shanghai, 1999, pp. 12–16.
3.
MeiX: Nutmeg and Mace. Foreign Med, 2007; 22:227–228.
4.
AssaJR, WidjanarkoSB, KusnadiJ, BerhimponS: Antioxidant potential of flesh, seed and mace of nutmeg (Myristica fragrans Houtt). Int J Chem Tech Res, 2014; 6:2460–2468.
5.
GuptaAD, BansalVK, BabuV, MaithilN: Chemistry, antioxidant and antimicrobial potential of nutmeg (Myristica fragrans Houtt). J Gene Eng Biotechnol, 2013; 11:25–31.
6.
CaoGY, XuW, YangXW, GonzalezFJ, LiF: New neolignans from the seeds of Myristica fragrans that inhibit nitric oxide production. Food Chem, 2015; 173:231–237.
7.
ThuongPT, HungTM, KhoiNM, NhungHTM, ChinhNT, QuyNT, et al.: Cytotoxic and anti-tumor activities of lignans from the seeds of Vietnamese nutmeg Myristica fragrans. Arch Pharm Res, 2014; 37:399–403.
8.
MoritaT, JinnoK, KawagishiH, ArimotoY, SuganumaH, InakumaT, et al.: Hepatoprotective effect of myristicin from nutmeg (Myristica fragrans) on lipopolysaccharide/d-galactosamine-induced liver injury. J Agric Food Chem, 2003; 51:1560–1565.
9.
LestariK, HwangJK, KariadiSH, WijayaA, AhmadT, SubarnasA, et al.: Screening for PPARγ agonist from Myristica fragrans Houtt seeds for the treatment of Type 2 diabetes by in vitro and in vivo. Med Health Sci J, 2012; 12:7–15.
10.
JanssensJ, LaekemanGM, PietersLA, TotteJ, HermanAG, VlietinckAJ: Nutmeg oil: Identification and quantitation of its most active constituents as inhibitors of platelet aggregation. J Ethnopharmacol, 1990; 29:179–188.
11.
CuongTD, HungTM, HanHY, RohHS, SeokJH, LeeJK, et al.: Potent acetylcholinesterase inhibitory compounds from Myristica fragrans. Nat Prod Commun, 2014; 9:499–502.
12.
XuZJ, GaoSX, ZhangM, ZouXZ: Studies on the chemical constituents of the ethanolic extracts from the stems of Myristica fragrans Houtt. Chin J Org Chem, 2007; 27:1254–1257.
13.
CuongTD, HungTM, NaM, KimJC, LeeD, RyooS, et al.: Inhibitory effect on NO production of phenolic compounds from Myristica fragrans. Bioorg Med Chem Lett, 2011; 21:6884–6887.
14.
ZhangL, XuYF, ShenS, ZengYM, PengQ, HaoSJ, et al.: Study on the chemical constituents from Myristica fragrans Houtt. Modern Chin Med, 2010; 12:16–19, 42.
15.
DasguptaN, RanjanS, MohammedSMA, JadonPS, MelvinSS, HarrisAD, et al.: Extraction-based blood coagulation activity of marigold leaf: A comparative study. Comp Clin Pathol, 2014; 23:1715–1718.
16.
JangDH, WeaverMD, PizonAF: In vitro study of N-acetylcysteine on coagulation factors in plasma samples from healthy subjects. J Med Toxicol, 2013; 9:49–53.
17.
TibbsRF, ElghetanyMT, TranLT, Van BonnW, RomanoT, CowanDF: Characterization of the coagulation system in healthy dolphins: The coagulation factors, natural anticoagulants, and fibrinolytic products. Comp Clin Pathol, 2005; 14:95–98.
18.
XiongLF, LiSR: Basis of Clinical Examination. People's Medical Publishing House, Beijing, 2003, pp. 88–93.
19.
JaegerBR, LabarrereCA: Fibrinogen und atherothrombose: Vulnerable plaque oder vulnerabler patient?. Herz, 2003; 28:530–538.
20.
ChenW: The Effect and Mechanism of Urokinase Type Plasminogen Activator Receptor (uPAR) on Atherosclerosis. PhD Thesis, Peking Union Medical College Hospital, Beijing, September2002.
21.
FuhrmanB: The urokinase system in the pathogenesis of atherosclerosis. Atherosclerosis, 2012; 222:8–14.
22.
HuY, XueH, WangK: Studies on coagulation and fibrinolysis. IV. Observation on coagulability and fibrinolytic activity in diabetics. Acta Acad Med Sin, 1983; 5:388–389.
23.
NguyenPH, LeTVT, HuWK, ChaeJ, SangKK, KwonKI, et al.: AMP-activated protein kinase (AMPK) activators from Myristica fragrans (nutmeg) and their anti-obesity effect. Bioorg Med Chem Lett, 2010; 20:4128–4131.
24.
YangS, NaMK, JangJP, KimKA, BoYK, SungNJ, et al.: Inhibition of protein tyrosine phosphatase 1b by lignans from Myristica fragrans. Phytother Res, 2006; 20:680–682.
25.
KawamuraT, EgusaG, FujikawaR, WatanabeT, OdaK, KataokaS, et al.: Effect of acarbose on glycemic control and lipid metabolism in patients with non-insulin-dependent diabetes mellitus. Curr Ther Res, 1998; 59:97–106.
26.
LiCF: Study on the Hypoglycemic Substances Targeting α-Glucosidase. Master Thesis, Hua Zhong Argicultural University, Wuhan, June2008.
27.
YinZ, ZhangW, FengF, ZhangY, KangW: α-Glucosidase inhibitors isolated from medicinal plants. Food Sci Human Wellness, 2014; 3:136–174.
28.
HuaD: Studies on Chemical Constituents of Paris polyphylla var. latifolia. Master Thesis, Fourth Military Medical University, Xi'an, May2015.
29.
GuHP, ZhouDP, GuXZ, KangWY: Effects of the Bracts and Bars of Zea mays L. on blood coagulation. Nat Prod Res Dev, 2013; 25:681–683.
30.
KuSK, KimTH, BaeJS: Anticoagulant activities of persicarin and isorhamnetin. Vasc Pharmacol, 2013; 58:272–279.
31.
MarshN, GaffneyP: The rapid fibrin plate-a method for plasminogen activator assay. Thromb and Haemostasis, 1977; 38:545–551.
32.
GuHP: Study on Blood Coagulation and Hepatoprotective Effect of Phlomis maximowiczii. Regel and Blood Coagulation of Psoralea corylifolia L. Master Thesis, Henan University, Kaifeng, July2014.
33.
KangWY, SongYL, ZhangL: α-Glucosidase inhibitory and antioxidant properties and antidiabetic activity of Hypericum ascyron L. Med Chem Res, 2011; 20:809–816.
34.
PhanMG, PhanTS, MatsunamiK, OtsukaH: New neolignans and lignans from Vietnamese medicinal plant Machilus odoratissima Nees. Chem Pharm Bull, 2006; 54:380.
35.
YangX, HuangX, AhmatM: New neolignan from seed of Myristica fragrans. Chin J Chin Mater Med, 2008; 33:397–402.
36.
HattoriM, HadaS, WatahikiA, IharaH, ShuY, KakiuchiN, et al.: Studies on dental caries prevention by traditional medicines. X. Antibacterial action of phenolic components from mace against Streptococcus mutans. Chem Pharm Bull, 1986; 34:3885.
37.
ChenLL, HanN, WangYC, HuangT, XueR, YinJ: The chemical constituents from whole plant of Reineckia carnea (Andr.) Kunth. J Shenyang Pharm Univ, 2011; 28:875–878.
38.
BasnetP, KadotaS, TerashimaS, ShimizuM, NambaT: Two new 2-arylbenzofuran derivatives from hypoglycemic activity-bearing fractions of Morus insignis. Chem Pharm Bull (Tokyo), 1993; 41:1238–1238.
39.
LaudesIJ, ChuJC, SikranthS, Huber-LangM, GuoRF, RiedemannN, et al.: Anti-C5a ameliorates coagulation/fibrinolytic protein changes in a rat model of sepsis. Am J Pathol, 2002; 160:1867–1875.
40.
KangJW, MinBS, LeeJH: Anti-platelet activity of erythro-(7 S,8 R)-7-acetoxy-3,4,3′,5′-tetramethoxy-8-O-4′-neolignan from Myristica fragrans. Phytother Res, 2013; 27:1694–1699.
41.
HangGQ, MaY, LiCL: The studies of natural PAF antagonistic neolignans from Piper genus and their structure—activity relationships. J Beijing Med Univ, 1992; 24:347–350.
42.
HuangL, LinCW, LiAY, WeiBY, TengJW, LiL: Pro-coagulant activity of phenolic acids isolated from Blumea riparia. Nat Prod Commun, 2010; 5:1263–1266.
43.
YanY, HuangY: A concrete analysis of procoagulant medicine. Chin Commun Doc, 2005; 6:10.
44.
OtaniY, TabataY, IkadaY: A new biological glue from gelatin and poly (L-glutamic acid). J Biomed Mater Res, 1996; 31:157–166.
45.
ZhangW, SunYL, ChenDH: Effects of chitin and sepia ink hybrid hemostatic sponge on the blood parameters of mice. Mar Drugs, 2014; 12:2269–2281.
